FTRE
Fortrea Holdings Inc.
FTRE lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
FTRE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Weak |
FTRE's cash flow is currently healthy, and its revenue and profitability are stable, but its balance sheet is weak.
FTRE PE Valuation
FTRE has no meaningful PE right now: it lost money over the past year.
FTRE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect FTRE's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
FTRE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.95 | — |
| Q3 2026 | -$0.63 | +$10.61 |
| Q2 2026 | -$0.81 | +$10.57 |
| Q1 2026 | -$4.81 | +$3.98 |
| Q4 2025 | -$10.81 | -$7.14 |
| Q3 2025 | -$11.24 | -$7.84 |
| Q2 2025 | -$11.38 | -$8.14 |
| Q1 2025 | -$8.79 | -$7.42 |
| Q4 2024 | -$3.67 | -$3.57 |
FTRE is still losing money, but far less than before: $0.63 per share over the past year, against $11.38 at its worst in mid-2025.
FTRE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $691.5M | -1.4% |
| Q2 2026 | $678.2M | -4.5% |
| Q1 2026 | $636.5M | -2.3% |
| Q4 2025 | $660.5M | -5.2% |
| Q3 2025 | $701.3M | +3.9% |
| Q2 2025 | $710.3M | +7.2% |
| Q1 2025 | $651.3M | -1.6% |
| Q4 2024 | $697M | -10% |
FTRE's revenue has held roughly level: $692M last quarter, down 1.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.2% | +3.4 points |
| Q2 2026 | 2.2% | +49 points |
| Q1 2026 | -0.5% | +79 points |
| Q4 2025 | -2.1% | +5.9 points |
| Q3 2025 | -1.2% | +1.4 points |
| Q2 2025 | -47% | -39 points |
| Q1 2025 | -80% | -74 points |
| Q4 2024 | -8% | -6.6 points |
FTRE's operating margin was 2.2% last quarter, up 3.4 points from the same quarter a year ago.
FTRE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $52.5M | -34% |
| Q2 2026 | $19.9M | +39% |
| Q1 2026 | -$25M | +$102.1M |
| Q4 2025 | $121.6M | +499% |
| Q3 2025 | $79.5M | +$90.1M |
| Q2 2025 | $14.3M | -95% |
| Q1 2025 | -$127.1M | -$92.2M |
| Q4 2024 | $20.3M | +577% |
FTRE's free cash flow has turned positive again: $169M over the past year, against −$13M the year before.
FTRE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 9.1x | High |
| Q2 2026 | 13.1x | High |
| Q2 2024 | 118.8x | High |
| Q1 2024 | 15.7x | High |
| Q4 2023 | 10.0x | High |
| Q3 2023 | 10.6x | High |
| Q2 2023 | 7.5x | High |
| Q1 2023 | 6.2x | High |
FTRE's net debt is about 9.1 years of its operating earnings (EBITDA), down from 10 years a year ago.
FTRE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.3 | Neutral |
| Stochastic | 49.9 | Neutral |
FTRE's weekly RSI is 55 (neutral) and its Stochastic is 50 (neutral).
FTRE PE vs Healthcare Sector
FTRE has no meaningful PE right now: it lost money over the past year.
FTRE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.3 | 5.7% below |
| 20 week MA | $19.5 | 3% above |
| 50 week MA | $15.9 | 26% above |
| 100 week MA | $12.9 | 56% above |
FTRE's trend is up, with a small recent dip: it's below only its 8-week average, and 56% above its 100-week average.
FTRE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $34.0 | $34.9 | +2.6% |
| 2024 | $34.9 | $19.4 | -45% |
| 2025 | $19.4 | $17.4 | -10% |
| 2026 YTD | $17.4 | $20.1 | +15% |
FTRE has finished lower in two of the last three years. It's up 15% so far in 2026.